Biostatistics & Bioinformatics Shared Resource

BBSR Home | Services & Fees | Educational Resources | Publications | Schedule

Publications

2003 2004 2005 2006 2007 2008

2004

Cotarla I, Ren S, Zhang Y, Gehan E, Singh B, Furth P. Stat5a is tyrosine phosphorylated and nuclear localized in a high proportion of human breast cancers. Int. J. Cancer 108(5): 665-671, 2004.

Kumar P, Sakabe I, Patel S, Zhang Y, Ahmad I, Gehan E, Whiteside TL, Kasid U. SCC-112, a novel cell cycle-regulated molecule, exhibits reduced expression in human renal carcinomas. Gene 328:187-196, 2004.

Stearns V, Gallagher A, Kleer CG, Singh B, Freedman M, Haddad BR, Isaacs C, Warren R, Brown M, Cullen J, Trock B, Hayes DF. A pilot study to establish a clinical model to perform phase II studies of breast cancer chemopreventive agents in women at high risk with biomarkers as surrogate endpoints for activity. Clin Cancer Res 10(24):8332-8340, 2004

Stearns V, Coop A, Singh B, Gallagher A, Yamauchi H, Lieberman R, Pennanen M, Trock B, Hayes DF, Ellis MJ. A pilot surrogate end point biomarker trial of perillyl alcohol in breast neoplasia. Clin Cancer Res 10(22):7583-7591, 2004.

Li H, Ahone TJ, Alanen K, Xie J, Pretlow TG, Zhang Y, Nurmi M, Singh B, Martikainen P, Nevalainen M. Activation of signal transducer and activator of transcription 5 (STAT 5) in human prostate cancer is associated with high histological grade. Cancer Research 64:4774-4782, 2004.

Marshall, JL, Eisenberg SG, Johnson MD, Hanfelt JJ, Dorr FA, El Ashry D, Oberst M, Fuxman Y, Holmlund J, Malik S. A phase II trial of ISIS 3521 in patients with metastatic colorectal cancer. Clin Colorectal Cancer 4:268-274, 2004.

Moroni M, Soldatenkov V, Zhang Yin, Zhang Y, Stoica G, Gehan E, Rashidi B, Singh B, Ozdemirli M, Mueller SC. Progressive loss of Syk and abnormal proliferation in breast cancer cells. Cancer Research 64:7346-7354, 2004.

Oh A, List H-J, Reiter R, Mani A, Zhang Y, Gehan E, Wellstein A, Riegel AT. The nuclear receptor coactivator AIB1 mediates IGF-1 induced phenotypic changes in human MCF-7 breast cancer cells. Cancer Research 64:8299-8308, 2004.

Pack SD, Alper OM, Stromberg K, Augustus M, Ozdemirli M, Miermont AM, Klus G, Rusin M, Slack R, Gacker NF, Ried T, Szallasi Z, Alper O. Simultaneous suppression of EGFR and c-erbB-2 reverses aneuploidy and malignant phenotype of a human ovarian carcinoma cell line. Cancer Research 64(3):789-94, 2004.

Zhang Y, Glass A, Bennett N, Oyama K, Gehan E, Gelmann E. Long-term outcomes after radical prostatectomy performed in a community-based health maintenance organization. Cancer 100(2):300-307, 2004.

Cowgill KD, Loffredo CA, Eissa SA, Mokhtar N, Abdel-Hamid M, Fahmy A, Strickland GT. Case-control study of non-Hodgkin's lymphoma and hepatitis C virus infection in Egypt. Int J Epidemiol 33(5):1034-1039, 2004.

Jung M, Zhang Y, Dimtchev A, Subramanian MR, Suthanthiran K, Dritschilo A. Interstitial gene delivery in human xenograft prostate tumors using titanium metal seeds. Mol. Cancer Ther. 3:655-659, 2004.

Wei Z, Xiao Y, Kellar KJ, Kozikowski AP. Synthesis and pharmacological characterization of bivalent analogues of epibatidine for neuronal nicotinic acetylcholine receptors. Bio. Med. Chem. Lett. 14:1855-1858, 2004.